A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Hondow, Heather L ^a   Fox, Stephen B ^a,b   Mitchell, Gillian ^a   Scott, Rodney J ^c   Beshay, Victoria ^a   Wong, Stephen Q ^a   Dobrovic, Alexander ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYINOSINE; DNA; PRIMER DNA;

AMPLICON; ARTICLE; BRCA2 GENE; CONTROLLED STUDY; DNA DETERMINATION; EXON; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HETEROZYGOTE; HIGH RESOLUTION MELTING ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; INTRON; MUTATIONAL ANALYSIS; ONCOGENE; PROCESS OPTIMIZATION; REPRODUCIBILITY; VALIDATION PROCESS; HIGH THROUGHPUT SCREENING; METHODOLOGY; MUTATION; NUCLEOTIDE SEQUENCE; SINGLE BLIND PROCEDURE; TUMOR SUPPRESSOR GENE; VALIDATION STUDY;

DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GERM-LINE MUTATION; HETEROZYGOTE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; POLYMORPHISM, GENETIC; SINGLE-BLIND METHOD;

EID: 79959389584     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-265     Document Type: Article

References (40)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1. Science 1994, 266:66-71. 10.1126/science.7545954, 7545954.
2. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994, 265:2088-2090. 10.1126/science.8091231, 8091231.
3. Narod SA, Foulkes WD. BRCA1 and BRCA2: 1994 and beyond. Nature Rev Cancer 2004, 4:665-676.
4. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72:1117-1130. 10.1086/375033, 1180265, 12677558.
5. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002, 346:1609-1615. 10.1056/NEJMoa020119, 12023992.
6. Rubinstein WS. Hereditary breast cancer: pathobiology, clinical translation, and potential for targeted cancer therapeutics. Fam Cancer 2008, 7:83-89. 10.1007/s10689-007-9147-7, 17624601.
7. Chou LS, Lyon E, Wittwer CT. A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model. Am J Clin Pathol 2005, 124:330-338. 10.1309/BF3MLJN8J527MWQY, 16191501.
8. Sadr-Nabavi A, Hoffman M, Weilke C, Sun YL, Nevinny-Stickel-Hinzpeter C. Mutation Scanning Using High Resolution Melting or dHPLC: a Performance Comparison Study. Biochemica 2009, 4:30-33.
9. Reed GH, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 2004, 50:1748-1754. 10.1373/clinchem.2003.029751, 15308590.
10. Montgomery J, Wittwer CT, Kent JO, Zhou L. Scanning the cystic fibrosis transmembrane conductance regulator gene using high-resolution DNA melting analysis. Clin Chem 2007, 53:1891-1898. 10.1373/clinchem.2007.092361, 17890437.
11. Ravnik-Glavac M, Atkinson A, Glavac D, Dean M. DHPLC screening of cystic fibrosis gene mutations. Hum Mutat 2002, 19:374-83. 10.1002/humu.10065, 11933191.
12. The Poland thermal denaturation profile program. , http://www.biophys.uni-duesseldorf.de/local/POLAND//poland.html
13. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003, 49:853-60. 10.1373/49.6.853, 12765979.
14. Reed GH, Kent JO, Wittwer CT. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 2007, 8:597-608. 10.2217/14622416.8.6.597, 17559349.
15. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV. Expanded Instrument Comparison of Amplicon DNA Melting Analysis for Mutation Scanning and Genotyping. Clin Chem 2007, 53:1544-1548. 10.1373/clinchem.2007.088120, 17556647.
16. Oligo Calc: Oligonucleotide Properties Calculator. , http://www.basic.northwestern.edu/biotools/oligocalc.html
17. Amplify 3 program for MacOS X. , http://engels.genetics.wisc.edu/amplify/
18. NHGRI Breast Cancer Information Core Database. , http://research.nhgri.nih.gov/bic/
19. Kuschel B, Gayther SA, Easton DF, Ponder BA, Pharoah PD. Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testing. Genes Chromosomes Cancer 2001, 31:96-98. 10.1002/gcc.1122, 11284041.
20. Solano AR, Dourisboure RJ, Weitzel J, Podesta EJ. A cautionary note: false homozygosity for BRCA2 6174delT mutation resulting from a single nucleotide polymorphism masking the wt allele. Eur J Hum Genet 2002, 10:395-397. 10.1038/sj.ejhg.5200821, 12080393.
21. Single Nucleotide Polymorphism BLAST. , http://www.ncbi.nlm.nih.gov/SNP/snpblastByChr.html
22. Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D, Solomon E. The 5' end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 1996, 12:2507-2513.
23. Shen Z, Liu J, Wells RL, Elkind MM. Direct sequencing with highly degenerate and inosine-containing primers. Methods Mol Biol 1996, 65:111-118.
24. Mikeska T, Dobrovic A. Validation of a primer optimisation matrix to improve the performance of reverse transcription-quantitative real-time PCR assays. BMC Res Notes 2009, 2:112. 10.1186/1756-0500-2-112, 2706253, 19549292.
25. Van der Stoep N, van Paridon CDM, Janssens T, Krenkova P, Stambergova A, Macek M, Matthijs G, Bakker E. Diagnostic Guidelines for High-Resolution Melting Curve (HRM) Analysis: An Interlaboratory Validation of BRCA1 Mutation Scanning Using the 96-Well LightScannerTM. Hum Mutat 2009, 30:899-909. 10.1002/humu.21004, 19370767.
26. De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K. Rapid and Sensitive Detection of BRCA1/2 Mutations in a Diagnostic Setting: Comparison of Two High-Resolution Melting Platforms. Clin Chem 2008, 54:982-989. 10.1373/clinchem.2007.098764, 18403564.
27. de Juan I, Esteban E, Palanca S, Barragán E, Bolufer P. High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations. Breast Cancer Res Treat 2009, 115:405-414. 10.1007/s10549-008-0073-7, 18528753.
28. Kennerson ML, Warburton T, Nelis E, Brewer M, Polly P, De Jonghe P, Timmerman V, Nicholson GA. Mutation scanning the GJB1 gene with high-resolution melting analysis: implications for mutation scanning of genes for Charcot-Marie-Tooth disease. Clin Chem 2007, 53:349-352.
29. Martino A, Mancuso T, Rossi AM. Application of high-resolution melting to large-scale, high-throughput SNP genotyping: a comparison with the TaqMan method. J Biomol Screen 2010, 15:623-629. 10.1177/1087057110365900, 20371868.
30. Montgomery JL, Sanford LN, Wittwer CT. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 2010, 10:219-240. 10.1586/erm.09.84, 20214540.
31. Wagner T, Stoppa-Lyonnet D, Fleischmann E, Muhr D, Pagès S, Sandberg T, Caux V, Moeslinger R, Langbauer G, Borg A, Oefner P. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 1999, 62:369-376. 10.1006/geno.1999.6026, 10644434.
32. Dufresne SD, Belloni DR, Wells WA, Tsongalis GJ. BRCA1 and BRCA2 mutation screening using SmartCycler II high-resolution melt curve analysis. Arch Pathol Lab Med 2006, 130:185-187.
33. Takano EA, Mitchell G, Fox SB, Dobrovic A. Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis. BMC Cancer 2008, 8:59. 10.1186/1471-2407-8-59, 2266761, 18298804.
34. Vorkas PA, Christopoulos K, Kroupis C, Lianidou ES. Mutation Scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis. Clin Biochem 2009, 43:178-185.
35. Kwong A, Ng EKO, Law FBF, Wong LP, To MY, Cheung MT, Wong HN, Chan VW, Kurian A, West DW, Ford JM, Ma ESK. High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. Breast Cancer Res Treat 2009, 122:605-607.
36. Coulet F, Pires F, Rouleau E, Lefol C, Martin S, Colas C, Cohen-Haguenauer O, Giurga I, Fajac A, Nogue's C, Demange L, Hardouin A, Lidereau R, Soubrier F. A One-Step Prescreening for Point Mutations and Large Rearrangement in BRCA1 and BRCA2 Genes Using Quantitative Polymerase Chain Reaction and High-Resolution Melting Curve Analysis. Genet Test Mol Biomarkers 2010, 14:677-690. 10.1089/gtmb.2009.0183, 20858050.
37. Zhou L, Wang L, Palais R, Pryor R, Wittwer CT. High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution. Clin Chem 2005, 51:1770-1777. 10.1373/clinchem.2005.054924, 16189378.
38. De Leeneer K, Coene I, Poppe B, De Paepe A, Claes K. Technical Advance Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes. J Mol Diagn 2009, 11:415-419. 10.2353/jmoldx.2009.090032, 2729838, 19644020.
39. Krypuy M, Newnham GM, Thomas DM, Conron M, Dobrovic A. High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer. BMC Cancer 2006, 6:295. 10.1186/1471-2407-6-295, 1769510, 17184525.
40. Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ, DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A. High resolution melting for mutation scanning of TP53 exons 5-8. BMC Cancer 2007, 7:168. 10.1186/1471-2407-7-168, 2025602, 17764544.